VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) hit a new 52-week low during trading on Thursday. The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 168,430 shares. The stock had previously closed at C$0.07.
VentriPoint Diagnostics Price Performance
The business’s 50-day moving average price is C$0.09 and its 200 day moving average price is C$0.11. The company has a quick ratio of 6.67, a current ratio of 0.12 and a debt-to-equity ratio of -68.25. The company has a market capitalization of C$13.63 million, a P/E ratio of -3.50 and a beta of -1.31.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
